Diagnostics
Although at-home testing for COVID-19 has been dismal, the revolution in at-home testing has inspired personal tests for several other illnesses.
A recent study, published in Genetics in Medicine, concluded that genetic variants contributed to SUPD in 11% of the 352 cases.
“We were founded on the premise of felines first, and have been called ‘23andMeow,’ Anna Skaya, founder and CEO, told BioSpace.
Up to 40% of AD patients were found to have Lewy Bodies in their brain after succumbing to the disease.
Microbiologics, Inc. commemorated its 50th anniversary in 2021 by playing a key role in helping the world manage the COVID-19 pandemic.
You are what you eat, and your defense system notices that.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Roche’s investment is aimed at supporting the development of Freenome’s colorectal cancer detection technology.
Sigyn is not only trying to treat the inflammatory mediators that fuel sepsis; it wants to prevent the life-threatening event from occurring altogether.
SomaLogic and Illumina have come together to propel innovation in Proteomics. This partnership represents the rapidly growing high throughput sector of the proteomics market
PRESS RELEASES